FIT-话题@MedSci - 梅斯（MedSci）

#FIT#

40篇内容 | 2099人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1331964, encodeId=95dc1331964f4, content=<a href='/topic/show?id=eac1e47058' target=_blank style='color:#2F92EE;'>#FIT#</a>, objectTitle=Gastric Cancer: 粪便免疫化学试验 (FIT)也可以进行幽门螺杆菌粪便抗原检测, objectType=article, longId=221721, objectId=a2e5221e21af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2e5221e21af, replyNumber=0, likeNumber=71, createdTime=2021-12-10, rootId=0, userName=12498768m13(暂无昵称), userId=ac782500066, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2e5221e21af, moduleTitle=Gastric Cancer: 粪便免疫化学试验 (FIT)也可以进行幽门螺杆菌粪便抗原检测, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a2e5221e21af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1331963, encodeId=db1213319632e, content=<a href='/topic/show?id=eac1e47058' target=_blank style='color:#2F92EE;'>#FIT#</a>, objectTitle=J Clin Oncol：新型双特异性抗体Glofitamab用于难治性侵袭性B细胞非霍奇金淋巴瘤的活性, objectType=article, longId=208782, objectId=0413208e8273, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0413208e8273, replyNumber=0, likeNumber=65, createdTime=2021-03-22, rootId=0, userName=12498768m13(暂无昵称), userId=ac782500066, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0413208e8273, moduleTitle=J Clin Oncol：新型双特异性抗体Glofitamab用于难治性侵袭性B细胞非霍奇金淋巴瘤的活性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0413208e8273)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1331962, encodeId=833f133196260, content=<a href='/topic/show?id=eac1e47058' target=_blank style='color:#2F92EE;'>#FIT#</a>, objectTitle=Br J Cancer：粪便免疫化学测试（FIT）：结直肠癌低危症状患者的诊断新选择, objectType=article, longId=206139, objectId=a0452061396b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0452061396b, replyNumber=0, likeNumber=82, createdTime=2021-01-24, rootId=0, userName=12498768m13(暂无昵称), userId=ac782500066, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0452061396b, moduleTitle=Br J Cancer：粪便免疫化学测试（FIT）：结直肠癌低危症状患者的诊断新选择, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a0452061396b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1331961, encodeId=1f7713319615e, content=<a href='/topic/show?id=eac1e47058' target=_blank style='color:#2F92EE;'>#FIT#</a>, objectTitle=使用iFit ActivePulse™实现个人化的自动心率训练, objectType=article, longId=205742, objectId=274e205e42d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=274e205e42d8, replyNumber=0, likeNumber=66, createdTime=2021-01-16, rootId=0, userName=12498768m13(暂无昵称), userId=ac782500066, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=274e205e42d8, moduleTitle=使用iFit ActivePulse™实现个人化的自动心率训练, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=274e205e42d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1331960, encodeId=0a9f13319605a, content=<a href='/topic/show?id=eac1e47058' target=_blank style='color:#2F92EE;'>#FIT#</a>, objectTitle=Self Esteem Brands祝贺Anytime Fitness主加盟商在东京证券交易所成功完成首次公开募股(IPO), objectType=article, longId=204648, objectId=08b22046481b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=08b22046481b, replyNumber=0, likeNumber=68, createdTime=2020-12-20, rootId=0, userName=12498768m13(暂无昵称), userId=ac782500066, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=08b22046481b, moduleTitle=Self Esteem Brands祝贺Anytime Fitness主加盟商在东京证券交易所成功完成首次公开募股(IPO), moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=08b22046481b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1331959, encodeId=008f1331959d6, content=<a href='/topic/show?id=eac1e47058' target=_blank style='color:#2F92EE;'>#FIT#</a>, objectTitle=J Sports Med Phys Fitness：简化太极运动可缓解轻度至中度帕金森病患者的症状, objectType=article, longId=198683, objectId=e9e21986834f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9e21986834f, replyNumber=0, likeNumber=90, createdTime=2020-08-05, rootId=0, userName=12498768m13(暂无昵称), userId=ac782500066, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9e21986834f, moduleTitle=J Sports Med Phys Fitness：简化太极运动可缓解轻度至中度帕金森病患者的症状, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e9e21986834f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1331958, encodeId=6b481331958cf, content=<a href='/topic/show?id=eac1e47058' target=_blank style='color:#2F92EE;'>#FIT#</a>, objectTitle=J Sports Med Phys Fitness：咖啡因不会改变男性运动时的血清睾丸激素水平, objectType=article, longId=196420, objectId=d9011964206d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9011964206d, replyNumber=0, likeNumber=83, createdTime=2020-06-26, rootId=0, userName=12498768m13(暂无昵称), userId=ac782500066, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9011964206d, moduleTitle=J Sports Med Phys Fitness：咖啡因不会改变男性运动时的血清睾丸激素水平, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d9011964206d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1331957, encodeId=de66133195e9e, content=<a href='/topic/show?id=eac1e47058' target=_blank style='color:#2F92EE;'>#FIT#</a>, objectTitle=EHA 2020：罗氏的CD20xCD3双特异性抗体glofitamab治疗淋巴瘤的新近进展, objectType=article, longId=195825, objectId=27f019582522, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27f019582522, replyNumber=0, likeNumber=128, createdTime=2020-06-15, rootId=0, userName=12498768m13(暂无昵称), userId=ac782500066, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27f019582522, moduleTitle=EHA 2020：罗氏的CD20xCD3双特异性抗体glofitamab治疗淋巴瘤的新近进展, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=27f019582522)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1331956, encodeId=f93f133195663, content=<a href='/topic/show?id=eac1e47058' target=_blank style='color:#2F92EE;'>#FIT#</a>, objectTitle=NEJM：Fitz-Hugh–Curtis综合征-病例报道, objectType=article, longId=183712, objectId=d400183e128f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d400183e128f, replyNumber=0, likeNumber=113, createdTime=2019-11-29, rootId=0, userName=12498768m13(暂无昵称), userId=ac782500066, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d400183e128f, moduleTitle=NEJM：Fitz-Hugh–Curtis综合征-病例报道, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d400183e128f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1331955, encodeId=2384133195560, content=<a href='/topic/show?id=eac1e47058' target=_blank style='color:#2F92EE;'>#FIT#</a>, objectTitle=BMS和辉瑞宣布与Fitbit合作推动房颤可穿戴设备的及时诊断, objectType=article, longId=181604, objectId=b52018160411, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b52018160411, replyNumber=0, likeNumber=0, createdTime=2019-10-21, rootId=0, userName=12498768m13(暂无昵称), userId=ac782500066, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b52018160411, moduleTitle=BMS和辉瑞宣布与Fitbit合作推动房颤可穿戴设备的及时诊断, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b52018160411)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1331954, encodeId=ecd5133195499, content=<a href='/topic/show?id=eac1e47058' target=_blank style='color:#2F92EE;'>#FIT#</a>, objectTitle=GUT：粪便免疫化学测试（FIT）在筛查结直肠癌和息肉切除术后中复发的监测作用, objectType=article, longId=177869, objectId=306a1e7869b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=306a1e7869b8, replyNumber=0, likeNumber=69, createdTime=2019-08-19, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=306a1e7869b8, moduleTitle=GUT：粪便免疫化学测试（FIT）在筛查结直肠癌和息肉切除术后中复发的监测作用, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=306a1e7869b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1331953, encodeId=da5713319536b, content=<a href='/topic/show?id=eac1e47058' target=_blank style='color:#2F92EE;'>#FIT#</a>, objectTitle=Cell Death Dis：IFITM3能够促进前列腺癌细胞的骨转移, objectType=article, longId=176001, objectId=054c1e6001d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=054c1e6001d7, replyNumber=0, likeNumber=91, createdTime=2019-07-24, rootId=0, userName=12498768m13(暂无昵称), userId=ac782500066, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=054c1e6001d7, moduleTitle=Cell Death Dis：IFITM3能够促进前列腺癌细胞的骨转移, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=054c1e6001d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1331952, encodeId=d99e1331952a9, content=<a href='/topic/show?id=eac1e47058' target=_blank style='color:#2F92EE;'>#FIT#</a>, objectTitle=Clin Chem：基于fitc的结直肠癌筛查项目的质量监测如何？, objectType=article, longId=175849, objectId=35af1e584962, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35af1e584962, replyNumber=0, likeNumber=67, createdTime=2019-07-22, rootId=0, userName=12498768m13(暂无昵称), userId=ac782500066, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35af1e584962, moduleTitle=Clin Chem：基于fitc的结直肠癌筛查项目的质量监测如何？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=35af1e584962)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1331951, encodeId=d792133195140, content=<a href='/topic/show?id=eac1e47058' target=_blank style='color:#2F92EE;'>#FIT#</a>, objectTitle=Cell Death & Disease：IFIT5在膀胱癌上皮间质转化和恶化中的作用和机制研究, objectType=article, longId=168771, objectId=4c79168e71ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4c79168e71ec, replyNumber=0, likeNumber=78, createdTime=2019-06-21, rootId=0, userName=12498768m13(暂无昵称), userId=ac782500066, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4c79168e71ec, moduleTitle=Cell Death & Disease：IFIT5在膀胱癌上皮间质转化和恶化中的作用和机制研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4c79168e71ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1331950, encodeId=fd18133195087, content=<a href='/topic/show?id=eac1e47058' target=_blank style='color:#2F92EE;'>#FIT#</a>, objectTitle=新型CDK9小分子靶向药物FIT-039，有望治疗宫颈癌, objectType=article, longId=168049, objectId=57f4168049c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57f4168049c2, replyNumber=0, likeNumber=94, createdTime=2019-06-12, rootId=0, userName=12498768m13(暂无昵称), userId=ac782500066, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57f4168049c2, moduleTitle=新型CDK9小分子靶向药物FIT-039，有望治疗宫颈癌, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=57f4168049c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1331949, encodeId=99811331949d2, content=<a href='/topic/show?id=eac1e47058' target=_blank style='color:#2F92EE;'>#FIT#</a>, objectTitle=GENFIT宣布DSMB的积极建议，将继续进行Elafibranor治疗非酒精性脂肪性肝炎的3期临床研究, objectType=article, longId=166113, objectId=36251661133d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36251661133d, replyNumber=0, likeNumber=75, createdTime=2019-05-16, rootId=0, userName=12498768m13(暂无昵称), userId=ac782500066, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36251661133d, moduleTitle=GENFIT宣布DSMB的积极建议，将继续进行Elafibranor治疗非酒精性脂肪性肝炎的3期临床研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=36251661133d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1331948, encodeId=96f0133194821, content=<a href='/topic/show?id=eac1e47058' target=_blank style='color:#2F92EE;'>#FIT#</a>, objectTitle=转移性膀胱癌的**靶向治疗药物：Balversa（erdafitinib）在美国加速获批, objectType=article, longId=164214, objectId=c97916421410, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c97916421410, replyNumber=0, likeNumber=73, createdTime=2019-04-15, rootId=0, userName=12498768m13(暂无昵称), userId=ac782500066, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c97916421410, moduleTitle=转移性膀胱癌的**靶向治疗药物：Balversa（erdafitinib）在美国加速获批, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c97916421410)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1331947, encodeId=dfad133194e63, content=<a href='/topic/show?id=eac1e47058' target=_blank style='color:#2F92EE;'>#FIT#</a>, objectTitle=J Bone Miner Res：IFITM5突变引起的V型成骨不全的表型变异, objectType=article, longId=162797, objectId=25f6162e9742, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25f6162e9742, replyNumber=0, likeNumber=74, createdTime=2019-03-25, rootId=0, userName=12498768m13(暂无昵称), userId=ac782500066, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25f6162e9742, moduleTitle=J Bone Miner Res：IFITM5突变引起的V型成骨不全的表型变异, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=25f6162e9742)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1331946, encodeId=5cbe133194621, content=<a href='/topic/show?id=eac1e47058' target=_blank style='color:#2F92EE;'>#FIT#</a>, objectTitle=Blood：巨核细胞可通过诱导IFITM3表达预防病毒感染, objectType=article, longId=159552, objectId=034b159552a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=034b159552a8, replyNumber=0, likeNumber=82, createdTime=2019-02-08, rootId=0, userName=12498768m13(暂无昵称), userId=ac782500066, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=034b159552a8, moduleTitle=Blood：巨核细胞可通过诱导IFITM3表达预防病毒感染, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=034b159552a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1331945, encodeId=67171331945d2, content=<a href='/topic/show?id=eac1e47058' target=_blank style='color:#2F92EE;'>#FIT#</a>, objectTitle=Diabetic Med：以情绪为中心的教育计划在减少成人2型糖尿病（VEMOFIT）患者困扰的有效性, objectType=article, longId=152247, objectId=78d515224e1a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78d515224e1a, replyNumber=0, likeNumber=52, createdTime=2018-10-31, rootId=0, userName=12498768m13(暂无昵称), userId=ac782500066, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78d515224e1a, moduleTitle=Diabetic Med：以情绪为中心的教育计划在减少成人2型糖尿病（VEMOFIT）患者困扰的有效性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=78d515224e1a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

FIT

2020-05-29

12498768m13(暂无昵称) (审核中...)

前往app查看评论内容

#FIT#

Gastric Cancer: 粪便免疫化学试验 (FIT)也可以进行幽门螺杆菌粪便抗原检测

2021-12-10

12498768m13(暂无昵称) (审核中...)

前往app查看评论内容

#FIT#

J Clin Oncol：新型双特异性抗体Glofitamab用于难治性侵袭性B细胞非霍奇金淋巴瘤的活性

2021-03-22

12498768m13(暂无昵称) (审核中...)

前往app查看评论内容

#FIT#

Br J Cancer：粪便免疫化学测试（FIT）：结直肠癌低危症状患者的诊断新选择

2021-01-24

12498768m13(暂无昵称) (审核中...)

前往app查看评论内容

#FIT#

使用iFit ActivePulse™实现个人化的自动心率训练

2021-01-16

12498768m13(暂无昵称) (审核中...)

前往app查看评论内容

#FIT#

Self Esteem Brands祝贺Anytime Fitness主加盟商在东京证券交易所成功完成首次公开募股(IPO)

2020-12-20

12498768m13(暂无昵称) (审核中...)

前往app查看评论内容

#FIT#

J Sports Med Phys Fitness：简化太极运动可缓解轻度至中度帕金森病患者的症状

2020-08-05

12498768m13(暂无昵称) (审核中...)

前往app查看评论内容

#FIT#

J Sports Med Phys Fitness：咖啡因不会改变男性运动时的血清睾丸激素水平

2020-06-26

12498768m13(暂无昵称) (审核中...)

前往app查看评论内容

#FIT#

EHA 2020：罗氏的CD20xCD3双特异性抗体glofitamab治疗淋巴瘤的新近进展

2020-06-15

12498768m13(暂无昵称) (审核中...)

前往app查看评论内容

#FIT#

NEJM：Fitz-Hugh–Curtis综合征-病例报道

2019-11-29

12498768m13(暂无昵称) (审核中...)

前往app查看评论内容

#FIT#

BMS和辉瑞宣布与Fitbit合作推动房颤可穿戴设备的及时诊断

2019-10-21

仁医06 (审核中...)

前往app查看评论内容

#FIT#

GUT：粪便免疫化学测试（FIT）在筛查结直肠癌和息肉切除术后中复发的监测作用

2019-08-19

12498768m13(暂无昵称) (审核中...)

前往app查看评论内容

#FIT#

Cell Death Dis：IFITM3能够促进前列腺癌细胞的骨转移

2019-07-24

12498768m13(暂无昵称) (审核中...)

前往app查看评论内容

#FIT#

Clin Chem：基于fitc的结直肠癌筛查项目的质量监测如何？

2019-07-22

12498768m13(暂无昵称) (审核中...)

前往app查看评论内容

#FIT#

Cell Death & Disease：IFIT5在膀胱癌上皮间质转化和恶化中的作用和机制研究

2019-06-21

12498768m13(暂无昵称) (审核中...)

前往app查看评论内容

#FIT#

新型CDK9小分子靶向药物FIT-039，有望治疗宫颈癌

2019-06-12

12498768m13(暂无昵称) (审核中...)

前往app查看评论内容

#FIT#

GENFIT宣布DSMB的积极建议，将继续进行Elafibranor治疗非酒精性脂肪性肝炎的3期临床研究

2019-05-16

12498768m13(暂无昵称) (审核中...)

前往app查看评论内容

#FIT#

转移性膀胱癌的**靶向治疗药物：Balversa（erdafitinib）在美国加速获批

2019-04-15

12498768m13(暂无昵称) (审核中...)

前往app查看评论内容

#FIT#

J Bone Miner Res：IFITM5突变引起的V型成骨不全的表型变异

2019-03-25

12498768m13(暂无昵称) (审核中...)

前往app查看评论内容

#FIT#

Blood：巨核细胞可通过诱导IFITM3表达预防病毒感染

2019-02-08

12498768m13(暂无昵称) (审核中...)

前往app查看评论内容

#FIT#

Diabetic Med：以情绪为中心的教育计划在减少成人2型糖尿病（VEMOFIT）患者困扰的有效性

2018-10-31

科室
- - 订阅+
  - 更多科室
工具
服务